Cumberland Pharmaceuticals (CPIX) Net Cash Flow Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.69 Bn | 30.75 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.61 Bn | 23.55 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.84 Bn | 16.53 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -1,020.00% |
| 10 | Cumberland Pharmaceuticals | 99.63 Mn | 88.63 Mn | 7.20 Mn | 84.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.68% |
| Dec 31, 2025 | -851.27% |
| Sep 30, 2025 | -794.06% |
| Jun 30, 2025 | 180.76% |
| Mar 31, 2025 | -1,358.82% |
| Dec 31, 2024 | 368.02% |
| Sep 30, 2024 | -50.44% |
| Jun 30, 2024 | -165.06% |
| Mar 31, 2024 | 106.73% |
| Dec 31, 2023 | -186.10% |
| Sep 30, 2023 | -80.46% |
| Jun 30, 2023 | 96.14% |
| Mar 31, 2023 | 65.50% |
| Dec 31, 2022 | -91.95% |
| Sep 30, 2022 | 200.51% |
| Jun 30, 2022 | 27.05% |
| Mar 31, 2022 | -5,879.04% |
| Dec 31, 2021 | 242.05% |
| Sep 30, 2021 | -304.62% |
| Jun 30, 2021 | 172.97% |